• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B细胞:类风湿关节炎治疗的合理靶点。

B-cell: a logical target for treatment of rheumatoid arthritis.

作者信息

Youinou P, Jamin C, Saraux A

机构信息

Laboratory of Immunology, Brest University Medical School Hospital, Brest, France.

出版信息

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28.

PMID:17543163
Abstract

The interest for B-cells in rheumatoid arthritis (RA) is currently being revived. They are involved in the development and activation of lymphoid architecture by regulating dentritic cell and T-cell function through cytokine production. Receptor editing an revising are also essential in B-cells and aid in preventing autoimmunity. Abnormalities in the subset distribution and a default in any task assigned to the B-cells may favor autoimmunity. Beneficied responses to B-cell depletion in RA by anti-CD20 monoclonal antibody rituximab illustrate the importance of B-lymphocytes in the pathogenesis of this disease. A new avenue has thus been opened, whereby B-lymphocytes return as a significant contributor to autoimmune disorders.

摘要

目前,类风湿关节炎(RA)中B细胞再次受到关注。它们通过细胞因子的产生调节树突状细胞和T细胞功能,从而参与淋巴结构的发育和激活。受体编辑和修正对B细胞也至关重要,并有助于预防自身免疫。B细胞亚群分布异常以及分配给B细胞的任何任务出现缺陷都可能有利于自身免疫。抗CD20单克隆抗体利妥昔单抗对RA中B细胞耗竭的有益反应说明了B淋巴细胞在该疾病发病机制中的重要性。因此,一条新途径已经开启,即B淋巴细胞再次成为自身免疫性疾病的重要促成因素。

相似文献

1
B-cell: a logical target for treatment of rheumatoid arthritis.B细胞:类风湿关节炎治疗的合理靶点。
Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28.
2
B cells, be gone--B-cell depletion in the treatment of rheumatoid arthritis.B细胞,消失吧——类风湿关节炎治疗中的B细胞清除疗法
N Engl J Med. 2004 Jun 17;350(25):2546-8. doi: 10.1056/NEJMp048114.
3
B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.类风湿关节炎的B细胞疗法:利妥昔单抗(抗CD20)的应用经验
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii55-9. doi: 10.1136/ard.62.suppl_2.ii55.
4
Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.炎症性免疫疾病的治疗 4. 在炎症性自身免疫疾病中使用抗CD20抗体利妥昔单抗的B细胞靶向治疗。
Intern Med. 2007;46(16):1313-5. doi: 10.2169/internalmedicine.46.1914. Epub 2007 Aug 15.
5
[Targeting CD20 in rheumatoid arthritis].[靶向类风湿关节炎中的CD20]
Nihon Rinsho. 2007 Jul;65(7):1243-9.
6
Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis.利妥昔单抗:用于治疗类风湿关节炎的新型B细胞清除疗法。
Expert Opin Pharmacother. 2006 Dec;7(18):2559-70. doi: 10.1517/14656566.7.18.2559.
7
Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results.利妥昔单抗免疫调节滑膜效应评估(ARISE试验)。1:临床和滑膜生物标志物结果。
Ann Rheum Dis. 2008 Mar;67(3):402-8. doi: 10.1136/ard.2007.074229. Epub 2007 Jul 20.
8
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis.除类风湿关节炎之外的自身免疫性疾病的 B 细胞耗竭治疗的现状。
Autoimmun Rev. 2009 Dec;9(2):82-9. doi: 10.1016/j.autrev.2009.08.007. Epub 2009 Aug 27.
9
[Anti-CD20 antibody therapy for inflammatory immune diseases].[抗CD20抗体疗法用于炎症性免疫疾病]
Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1801-6. doi: 10.2169/naika.95.1801.
10
Long term treatment of rheumatoid arthritis with rituximab.利妥昔单抗用于类风湿关节炎的长期治疗。
Autoimmun Rev. 2009 Jun;8(7):591-4. doi: 10.1016/j.autrev.2009.02.008. Epub 2009 Feb 11.

引用本文的文献

1
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.自身免疫性疾病和炎症性疾病靶向治疗的共同发展:一项系统性重新利用分析
Ther Adv Musculoskelet Dis. 2020 Dec 16;12:1759720X20969261. doi: 10.1177/1759720X20969261. eCollection 2020.
2
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.原发性可手术浸润性导管乳腺癌患者淋巴细胞亚群与临床病理生存决定因素的关系。
Br J Cancer. 2013 Sep 17;109(6):1676-84. doi: 10.1038/bjc.2013.493. Epub 2013 Aug 27.
3
KRN/I-Ag7 mouse arthritis is independent of complement C3.
KRN/I-Ag7 关节炎与补体 C3 无关。
J Clin Immunol. 2011 Oct;31(5):857-63. doi: 10.1007/s10875-011-9562-2. Epub 2011 Jul 6.
4
Advances in rheumatology: new targeted therapeutics.风湿病学进展:新型靶向治疗药物。
Arthritis Res Ther. 2011 May 25;13 Suppl 1(Suppl 1):S5. doi: 10.1186/1478-6354-13-S1-S5.
5
Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.在ESPOIR队列中,早期类风湿性关节炎患者的B淋巴细胞活化标志物升高,且与疾病活动相关。
Arthritis Res Ther. 2009;11(4):R114. doi: 10.1186/ar2773. Epub 2009 Jul 23.
6
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.炎症与乳腺癌。平衡免疫反应:乳腺癌进展过程中适应性免疫细胞与先天性免疫细胞之间的相互作用
Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746.